Profil
Allan Wehnert is currently the Chief Executive Officer & Director at Orocidin AS since 2023.
He is also currently serving as the Senior Vice President-Clinical, R&D Strategy at Initiator Pharma A since 2020.
Previously, he worked at H.
Lundbeck A as the VP-R&D Project Strategy & Portfolio Management.
Postes actifs de Allan Wehnert
| Sociétés | Poste | Début |
|---|---|---|
| INITIATOR PHARMA A/S | Directeur Technique/Scientifique/R&D | 01/12/2020 |
Anciens postes connus de Allan Wehnert
| Sociétés | Poste | Fin |
|---|---|---|
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
9
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| H. LUNDBECK A/S | Health Technology |
| INITIATOR PHARMA A/S | Health Technology |
